Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.

Roetker NS, Peng Y, Ashfaq A, Gilbertson DT, Wetmore JB.

Am J Nephrol. 2019;49(3):225-232. doi: 10.1159/000497477. Epub 2019 Feb 28.

PMID:
30820015
2.

Early withdrawal and non-withdrawal death in the months following hemodialysis initiation: A retrospective cohort analysis.

Wetmore JB, Roetker NS, Gilbertson DT, Liu J.

Hemodial Int. 2019 Apr;23(2):261-272. doi: 10.1111/hdi.12723. Epub 2019 Feb 11.

PMID:
30741471
3.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
4.

Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.

Wetmore JB, Peng Y, Gilbertson DT, Liu J.

Am J Cardiol. 2019 Feb 15;123(4):598-604. doi: 10.1016/j.amjcard.2018.11.020. Epub 2018 Nov 24.

PMID:
30527770
5.

Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis.

Wetmore JB, Li S, Yan H, Xu H, Peng Y, Sinsakul MV, Liu J, Gilbertson DT.

PLoS One. 2018 Sep 26;13(9):e0203767. doi: 10.1371/journal.pone.0203767. eCollection 2018.

6.
7.

Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study.

Wetmore JB, Molony JT, Liu J, Peng Y, Herzog CA, Collins AJ, Gilbertson DT.

J Am Heart Assoc. 2018 Feb 13;7(4). pii: e007231. doi: 10.1161/JAHA.117.007231.

8.

Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis.

Wetmore JB, Yan H, Hu Y, Gilbertson DT, Liu J.

Am J Kidney Dis. 2018 Jun;71(6):831-841. doi: 10.1053/j.ajkd.2017.10.025. Epub 2018 Jan 10.

9.

Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.

Burns CM, Knopman DS, Tupper DE, Davey CS, Slinin YM, Lakshminarayan K, Rossom RC, Pederson SL, Gilbertson DT, Murray AM.

J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):393-399. doi: 10.1093/gerona/glx241.

10.

Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients.

Wetmore JB, Li S, Molony JT, Guo H, Herzog CA, Gilbertson DT, Peng Y, Collins AJ.

Am J Kidney Dis. 2018 Jan;71(1):123-132. doi: 10.1053/j.ajkd.2017.08.023. Epub 2017 Nov 20.

PMID:
29162336
11.

Variability in hemoglobin levels in hemodialysis patients in the current era: a retrospective cohort study.

Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB.

Clin Nephrol. 2017 Nov;88(11):254-265. doi: 10.5414/CN109031.

12.

Elevated intracranial pressure and reversible eye-tracking changes detected while viewing a film clip.

Kolecki R, Dammavalam V, Bin Zahid A, Hubbard M, Choudhry O, Reyes M, Han B, Wang T, Papas PV, Adem A, North E, Gilbertson DT, Kondziolka D, Huang JH, Huang PP, Samadani U.

J Neurosurg. 2018 Mar;128(3):811-818. doi: 10.3171/2016.12.JNS161265. Epub 2017 Jun 2.

PMID:
28574312
13.

Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.

Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, Collins AJ, Gilbertson DT.

Clin Epidemiol. 2017 May 9;9:267-277. doi: 10.2147/CLEP.S105613. eCollection 2017. Review.

14.

Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study.

Wetmore JB, Weinhandl ED, Zhou J, Gilbertson DT.

PLoS One. 2017 Jan 30;12(1):e0171098. doi: 10.1371/journal.pone.0171098. eCollection 2017.

15.

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.

Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ.

BMC Nephrol. 2016 Nov 4;17(1):166.

16.

The US Renal Data System "Pie Chart of Death".

Herzog CA, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Dec;68(6):986. doi: 10.1053/j.ajkd.2016.08.015. Epub 2016 Sep 20. No abstract available.

PMID:
27663038
17.

Data completeness as an unmeasured confounder in dialysis facility performance comparison with 1-year follow-up
.

Liu J, Krishnan M, Zhou J, Nieman KM, Peng Y, Gilbertson DT.

Clin Nephrol. 2016 Nov;86 (2016)(11):262-269.

PMID:
27641053
18.

The Healthy People 2020 Objectives for Kidney Disease: How Far Have We Come, and Where Do We Need to Go?

Wetmore JB, Liu J, Li S, Hu Y, Peng Y, Gilbertson DT, Collins AJ.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):200-209. doi: 10.2215/CJN.04210416. Epub 2016 Aug 30.

19.

The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.

Wetmore JB, Guo H, Liu J, Collins AJ, Gilbertson DT.

Kidney Int. 2016 Oct;90(4):853-60. doi: 10.1016/j.kint.2016.04.026. Epub 2016 Jul 15.

PMID:
27425855
20.

Geovariation in Fracture Risk among Patients Receiving Hemodialysis.

Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury BD.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1413-21. doi: 10.2215/CJN.11651115. Epub 2016 Jun 7.

21.

Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative.

Wetmore JB, Gilbertson DT, Liu J, Collins AJ.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1297-304. doi: 10.2215/CJN.12981215. Epub 2016 Mar 22.

22.

Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.

Molony JT, Monda KL, Li S, Beaubrun AC, Gilbertson DT, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2016 Aug;68(2):266-276. doi: 10.1053/j.ajkd.2016.02.038. Epub 2016 Mar 12.

PMID:
26980607
23.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ.

J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. Epub 2016 Feb 25.

24.

Shaping Public Health Initiatives in Kidney Diseases: The Peer Kidney Care Initiative.

Wetmore JB, Gilbertson DT, Collins AJ.

Blood Purif. 2016;41(1-3):151-8. doi: 10.1159/000441316. Epub 2016 Jan 15. Review.

25.

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.

Murray AM, Bell EJ, Tupper DE, Davey CS, Pederson SL, Amiot EM, Miley KM, McPherson L, Heubner BM, Gilbertson DT, Foley RN, Drawz PE, Slinin Y, Rossom RC, Lakshminarayan K, Vemuri P, Jack CR, Knopman DS.

Am J Kidney Dis. 2016 Apr;67(4):593-600. doi: 10.1053/j.ajkd.2015.11.008. Epub 2015 Dec 29.

26.

Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients.

Wetmore JB, Peng Y, Jackson S, Matlon TJ, Collins AJ, Gilbertson DT.

Clin Nephrol. 2016 Feb;85(2):101-11. doi: 10.5414/CN108626.

PMID:
26636331
27.

Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.

PMID:
26608680
28.

Infections Requiring Hospitalization in Patients on Hemodialysis.

Gilbertson DT, Wetmore JB.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2101-3. doi: 10.2215/CJN.10891015. Epub 2015 Nov 13. No abstract available.

29.

Administrative Data and the Philosopher's Stone: Turning Heart Failure Claims Data into Quantitative Assessment of Left Ventricular Ejection Fraction.

Bovitz T, Gilbertson DT, Herzog CA.

Am J Med. 2016 Feb;129(2):223-5. doi: 10.1016/j.amjmed.2015.10.003. Epub 2015 Oct 28.

PMID:
26519615
30.

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.

Weinhandl ED, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Jan;67(1):98-110. doi: 10.1053/j.ajkd.2015.07.014. Epub 2015 Aug 28.

31.

Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.

Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT.

Am J Nephrol. 2015;41(4-5):354-61. doi: 10.1159/000431335. Epub 2015 Jun 17.

PMID:
26107376
32.

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.

Collins AJ, Foley RN, Gilbertson DT, Chen SC.

Kidney Int Suppl (2011). 2015 Jun;5(1):2-7.

33.

Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.

Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson E Jr.

Am J Kidney Dis. 2015 Nov;66(5):802-12. doi: 10.1053/j.ajkd.2015.04.015. Epub 2015 May 23.

PMID:
26015277
34.

Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease.

Gill K, Fink JC, Gilbertson DT, Monda KL, Muntner P, Lafayette RA, Petersen J, Chertow GM, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):654-62. doi: 10.1002/pds.3779. Epub 2015 Apr 22.

PMID:
25903095
35.

Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.

Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2015 Jan;65(1):98-108. doi: 10.1053/j.ajkd.2014.06.015. Epub 2014 Jul 29.

PMID:
25085647
36.

Relative safety of peginesatide and epoetin alfa.

Weinhandl ED, Gilbertson DT, Collins AJ, Foley RN.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1003-11. doi: 10.1002/pds.3655. Epub 2014 Jun 6.

PMID:
24905967
37.

Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.

Liu J, Li S, Gilbertson DT, Monda KL, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2014 Oct;64(4):608-15. doi: 10.1053/j.ajkd.2014.04.012. Epub 2014 May 10.

PMID:
24820317
38.

Hemodialysis patient outcomes: provider characteristics.

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A.

Am J Nephrol. 2014;39(5):367-75. doi: 10.1159/000362286. Epub 2014 Apr 23.

39.

Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula.

Ishani A, Gilbertson DT, Kim D, Bradbury BD, Collins AJ.

Am J Nephrol. 2014;39(3):238-47. doi: 10.1159/000358843. Epub 2014 Mar 8.

40.

Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.

Kalra A, Shroff GR, Erlien D, Gilbertson DT, Herzog CA.

JACC Cardiovasc Imaging. 2014 Feb;7(2):206-7. doi: 10.1016/j.jcmg.2013.11.003. No abstract available.

41.

Early mortality in patients starting dialysis appears to go unregistered.

Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ.

Kidney Int. 2014 Aug;86(2):392-8. doi: 10.1038/ki.2014.15. Epub 2014 Feb 12.

42.

Provider and care characteristics associated with timing of dialysis initiation.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A.

Clin J Am Soc Nephrol. 2014 Feb;9(2):310-7. doi: 10.2215/CJN.04190413. Epub 2014 Jan 16. Erratum in: Clin J Am Soc Nephrol. 2014 Apr;9(4):829.

43.

Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.

Collins AJ, Monda KL, Molony JT, Li S, Gilbertson DT, Bradbury BD.

Am J Kidney Dis. 2014 Jun;63(6):997-1006. doi: 10.1053/j.ajkd.2013.10.052. Epub 2013 Dec 4.

PMID:
24315770
44.

Geographic disparities in patient travel for dialysis in the United States.

Stephens JM, Brotherton S, Dunning SC, Emerson LC, Gilbertson DT, Harrison DJ, Kochevar JJ, McClellan AC, McClellan WM, Wan S, Gitlin M.

J Rural Health. 2013 Fall;29(4):339-48. doi: 10.1111/jrh.12022. Epub 2013 Apr 11.

PMID:
24088208
45.

Predictors of provider-patient visit frequency during hemodialysis.

Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A.

Am J Nephrol. 2013;38(2):91-8. doi: 10.1159/000353565. Epub 2013 Jul 17.

46.

RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.

Gilbertson DT, Monda KL, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2013 Nov;62(5):919-28. doi: 10.1053/j.ajkd.2013.05.004. Epub 2013 Jun 28.

PMID:
23815986
47.

Long-term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States.

Leither MD, Shroff GR, Ding S, Gilbertson DT, Herzog CA.

Circulation. 2013 Jul 23;128(4):344-51. doi: 10.1161/CIRCULATIONAHA.113.002365. Epub 2013 Jun 19.

48.

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics.

Gilbertson DT, Peng Y, Arneson TJ, Dunning S, Collins AJ.

BMC Nephrol. 2013 Feb 20;14:44. doi: 10.1186/1471-2369-14-44.

49.

Red blood cell transfusion use in patients with chronic kidney disease.

Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD.

Nephrol Dial Transplant. 2013 Jun;28(6):1504-15. doi: 10.1093/ndt/gfs580. Epub 2013 Feb 6.

PMID:
23389999
50.

Association of provider-patient visit frequency and patient outcomes on hemodialysis.

Slinin Y, Guo H, Li S, Liu J, Ensrud K, Gilbertson DT, Collins AJ, Ishani A.

J Am Soc Nephrol. 2012 Sep;23(9):1560-7. doi: 10.1681/ASN.2012010051. Epub 2012 Jul 12.

Supplemental Content

Loading ...
Support Center